Sana Biotechnology recently announced that its CEO, Steve Harr, will present a business overview and updates on key drug candidates at two major healthcare conferences in early December. This upcoming ...

Sana Biotechnology (SANA) shares have caught the eye lately, with investors tracking shifts in the biotech landscape and the company’s ongoing pipeline developments. There is growing interest as Sana ...

We recently published 10 Small Stocks with Mighty Gains. Sana Biotechnology, Inc. (NASDAQ:SANA) is one of the top-performing stocks on Wednesday. Sana Biotechnology soared by 14.53 percent on ...

Sana Biotechnology Inc. (NASDAQ:SANA) is a must-buy penny stock according to analysts. On November 7, Bank of America Securities analyst Alec Stranahan reaffirmed a Buy rating on Sana Biotechnology ...

Nathy Peluso and Tokischa enjoyed more than their Latin Grammy nomination during their trip to Las Vegas. The pair got swept up in the city’s playful energy and, like any good tourists, couldn’t ...

Tokischa chatted with Billboard’s Jessica Roiz on the red carpet of the 2025 Latin Grammys. A daily briefing on what matters in the music industry Send us a tip using our anonymous form. A daily ...

Investors might want to bet on Sana Biotechnology (SANA), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one ...

Sana Biotechnology (SANA) caught investor attention after unveiling a focused strategy that prioritizes its SC451 type 1 diabetes and SG293 in vivo CAR T programs. In addition to recent positive ...

SEATTLE (AP) — SEATTLE (AP) — Sana Biotechnology Inc. (SANA) on Thursday reported a loss of $42.2 million in its third quarter. On a per-share basis, the Seattle-based company said it had a loss of 16 ...